Can furosemide (Lasix) and spironolactone (Aldactone) be administered via a Nasogastric Tube (NGT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration of Furosemide and Spironolactone via Nasogastric Tube

Both furosemide and spironolactone can be safely administered via nasogastric tube (NGT) after proper preparation, though care must be taken to ensure appropriate dosing and administration techniques.

Medication Preparation for NGT Administration

Furosemide

  • Furosemide tablets can be crushed and dissolved in water for NGT administration
  • The oral bioavailability of furosemide remains good in cirrhotic patients when administered via this route 1
  • Guidelines specifically note the "good oral bioavailability of furosemide in the patient with cirrhosis" which supports its use via enteral routes

Spironolactone

  • Spironolactone tablets can be crushed and mixed with water to create a suspension for NGT administration
  • No specific contraindications exist for administering spironolactone via NGT

Administration Technique

  1. Proper preparation:

    • Crush tablets completely into a fine powder
    • Mix with 15-30 mL of water to create a suspension
    • Ensure complete dissolution/suspension to prevent tube clogging
  2. Administration sequence:

    • Stop enteral feeding 30 minutes before medication administration
    • Flush tube with 15-30 mL of water before medication administration
    • Administer each medication separately with water flushes between medications
    • Flush with 15-30 mL of water after administration
    • Resume feeding 30-60 minutes after medication administration

Important Considerations

Potential Complications

  • Tube obstruction if medications are not properly crushed and dissolved 2, 3
  • Potential for drug-nutrient interactions if administered with enteral feeds 4
  • Risk of altered bioavailability compared to standard oral administration 2

Clinical Monitoring

  • Monitor electrolytes closely, particularly potassium, sodium, and magnesium levels
  • Watch for appropriate diuretic response
  • Assess for signs of dehydration or electrolyte imbalances

Dosing Considerations

  • Standard dosing can be maintained when switching from oral to NGT administration
  • The usual diuretic regimen consists of single morning doses of oral spironolactone and furosemide, beginning with 100 mg of spironolactone and 40 mg of furosemide 1
  • Maintain the 100 mg:40 mg ratio (spironolactone:furosemide) when adjusting doses to maintain normokalemia 1

Avoiding Common Pitfalls

  1. Never administer extended-release or enteric-coated formulations via NGT

    • Use immediate-release formulations of both medications
  2. Prevent drug-nutrient interactions

    • Always hold enteral feeding before and after medication administration
    • Separate medication administration from feeding times
  3. Prevent tube clogging

    • Ensure complete crushing of tablets
    • Use adequate dilution with water
    • Flush tube thoroughly before and after medication administration

By following these guidelines, furosemide and spironolactone can be effectively and safely administered via nasogastric tube while maintaining their therapeutic efficacy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Therapeutic concerns when oral medications are administered nasogastrically.

Journal of clinical pharmacy and therapeutics, 2013

Research

Errors of oral medication administration in a patient with enteral feeding tube.

Journal of research in pharmacy practice, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.